Public health officials in the UK have stated that the vaccines offer significant protection against the Delta variant of coronavirus, a hopeful sign as the highly transmissible strain spreads across the world. In addition, various studies from researchers in England and Scotland have found that two doses of vaccine will offer a considerable amount of protection against severe illness and hospitalization that is generally caused by the Covid-19 Delta variant.
The findings indicate that Covid-19 vaccines can protect people against new variants, despite the early concerns that said the new variants might elude them. In addition, though vaccine effectiveness against Delta is still very substantial, it is generally seen that people who receive two doses of vaccine are protected from severe illness and hospitalization, indicating that the vaccine is offering significant protection against new strains.
Recently, England's public health agency analyzed over 14,000 Delta cases and found that a double dose of the shot developed by Pfizer Inc. and BioNTech SE reduces the risk of hospitalization after infection with Delta by 96 percent. The doses of the vaccine developed by the University of Oxford and AstraZeneca reduce the overall risk by 92 percent, Public Health England said.